PharmaShots

APRIL 7, 2023

TG Therapeutics Receives EMA’s CHMP Positive Opinion of Briumvi (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis Date: Apr 3, 2023 | Tags: TG Therapeutics, Briumvi, Ublituximab-xiiy, Multiple Sclerosis, Regulatory, EMA, CHMP BMS Receives EMA’s CHMP Positive Opinion of Breyanzi (lisocabtagene maraleucel) for (..)

FDA 53

FDA Immunization 53

pharmaphorum

JANUARY 24, 2022

IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise. The post IBM sells off large parts of Watson Health business appeared first on.

Cerner 111

Cerner 111

pharmaphorum

NOVEMBER 19, 2021

Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. Given the impact of the pandemic alongside the publicity, particularly around vaccine development and roll out driven by governments, one could argue marketing by pharma for its vaccines hasn’t been needed. Pfizer is understood to have charged $19.50

Vaccines 135

Vaccines Communication 135